Logo 1 Logo 2

Clinical Trial Details

Trial ID: L2537
Source ID: NCT00567112
Associated Drug: 10 Mg Mk-0941 Dfc (Fasted)
Title: Study to Evaluate the Pharmacokinetics & Food Effect of MK-0941 in Adults With Type 2 Diabetes (MK-0941-009)
Acronym:
Status: COMPLETED
Study Results: YES
Results: https://ClinicalTrials.gov/show/NCT00567112/results
Conditions: Type 2 Diabetes Mellitus
Interventions: DRUG: 10 mg MK-0941 DFC (fasted)|DRUG: 10 mg MK-0941 OCT (after meal)|DRUG: 10 mg MK-0941 OCT (before meal)|DRUG: 10 mg MK-0941 OCT (fasted)
Outcome Measures: Primary: Area Under the Curve (AUC)(0-∞) for Oral Compressed Tablet (OCT) (Fasted) and Dry Filled Capsule (DFC) (Fasted), From study drug administration to 72 hours post-administration|Maximum Concentration (Cmax) for OCT (Fasted) and DFC (Fasted), From study drug administration to 72 hours post-administration|Time to Reach Cmax (Tmax) for OCT (Fasted) and DFC (Fasted), From study drug administration to 72 hours post-administration|Half Life (t½) for OCT (Fasted) and DFC (Fasted), From study drug administration to 72 hours post-administration | Secondary: AUC(0-∞) for OCT (Fasted) and OCT (After Meal), From study drug administration to 72 hours post-administration|Cmax of OCT (Fasted) and OCT (After Meal), From study drug administration to 72 hours post-administration|Tmax for OCT (Fasted) and OCT (After Meal), From study drug administration to 72 hours post-administration|t1/2 for OCT (Fasted) and OCT (After Meal), From study drug administration to 72 hours post-administration
Sponsor/Collaborators: Sponsor: Merck Sharp & Dohme LLC
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE1
Enrollment: 18
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT
Start Date: 2007-11
Completion Date: 2008-04
Results First Posted: 2012-09-05
Last Update Posted: 2015-03-23
Locations:
URL: https://clinicaltrials.gov/show/NCT00567112